TABLE 3.
Item | Group I | Group II | Group III | Group IV | SEM | P-value |
MDA, nmol/mL | 7.00a | 5.39b | 3.65c | 5.76b | 0.306 | <0.01 |
GSH, μmol/L | 16.46b | 17.12b | 21.08a | 19.81a | 0.494 | <0.01 |
SOD, U/mL | 65.32b | 68.83b | 74.31a | 76.31a | 1.164 | <0.01 |
GSH-Px, U/mL | 193.97 | 189.16 | 187.39 | 188.28 | 2.908 | 0.878 |
T-AOC, mmol/mL | 0.86 | 0.97 | 0.93 | 1.01 | 0.032 | 0.411 |
CAT, U/mL | 1.03 | 0.92 | 0.96 | 0.87 | 0.029 | 0.282 |
MDA, malonaldehyde; GSH, glutathione; SOD, superoxide dismutase; GSH-Px, glutathione peroxidase; T-AOC, total antioxidant capacity; CAT, Catalase.
1Group I (control group), Group II (150 mg/kg NSPases in basal diet), Group III (25 mg/kg Bacillus probiotics in basal diet), Group IV (150 mg/kg NSPases + 25 mg/kg Bacillus probiotics in basal diet).
2Data is the mean of 10 replicates per treatment.
a–cDifferent superscript letters in the same row indicate significant differences at P < 0.05.